ChengDu ShengNuo Biotec Co.,Ltd. announced that it expects to receive CNY 159.999992 million in funding from Nuode Asset Management Co., Ltd., Caitong Fund Management Co., Ltd., Sichuan Development Securities Investment Fund Management Co., Ltd., AEGON-Industrial Fund Management Co. Ltd., Huaan Securities Co., Ltd.
May 15, 2023
Share
ChengDu ShengNuo Biotec Co.,Ltd. announced a private placement to issue shares not more than 30% of total share capital for an aggregate gross proceeds of not more than CNY 160,000,000 on May 16, 2023. The company shall issue shares at a price not less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction will include participation from no more than 35 investors.
The shares to be issued shall have a hold period of 6 months from closing of the transaction. The transaction has been approved at the annual general shareholders meeting of 2022 and approved authorizing the company?s directorate for the transaction. The transaction is still subject to approval from Shenzhen Stock Exchange and the China Securities Regulatory Commission.
HUAAN SECURITIES CO., LTD. is a China-based securities company. The Company mainly operates its business through six segments, including securities brokerage business, futures brokerage business, proprietary business, investment banking business, asset management business, margin trading business. The Company is also involved in the investment consulting business and equity investment business through its subsidiaries. The Company mainly operates its business in domestic market.
ChengDu ShengNuo Biotec Co.,Ltd. announced that it expects to receive CNY 159.999992 million in funding from Nuode Asset Management Co., Ltd., Caitong Fund Management Co., Ltd., Sichuan Development Securities Investment Fund Management Co., Ltd., AEGON-Industrial Fund Management Co. Ltd., Huaan Securities Co., Ltd.